117 related articles for article (PubMed ID: 30465531)
21. Frontline treatment of acute myeloid leukemia in adults.
Tamamyan G; Kadia T; Ravandi F; Borthakur G; Cortes J; Jabbour E; Daver N; Ohanian M; Kantarjian H; Konopleva M
Crit Rev Oncol Hematol; 2017 Feb; 110():20-34. PubMed ID: 28109402
[TBL] [Abstract][Full Text] [Related]
22. Genetics and epigenetics of pediatric leukemia in the era of precision medicine.
Ramos KN; Ramos IN; Zeng Y; Ramos KS
F1000Res; 2018; 7():. PubMed ID: 30079227
[TBL] [Abstract][Full Text] [Related]
23. DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia.
Chen CW; Koche RP; Sinha AU; Deshpande AJ; Zhu N; Eng R; Doench JG; Xu H; Chu SH; Qi J; Wang X; Delaney C; Bernt KM; Root DE; Hahn WC; Bradner JE; Armstrong SA
Nat Med; 2015 Apr; 21(4):335-43. PubMed ID: 25822366
[TBL] [Abstract][Full Text] [Related]
24. Genomic complexity and dynamics of clonal evolution in childhood acute myeloid leukemia studied with whole-exome sequencing.
Masetti R; Castelli I; Astolfi A; Bertuccio SN; Indio V; Togni M; Belotti T; Serravalle S; Tarantino G; Zecca M; Pigazzi M; Basso G; Pession A; Locatelli F
Oncotarget; 2016 Aug; 7(35):56746-56757. PubMed ID: 27462774
[TBL] [Abstract][Full Text] [Related]
25. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.
Tao YF; Xu LX; Lu J; Hu SY; Fang F; Cao L; Xiao PF; Du XJ; Sun LC; Li ZH; Wang NN; Su GH; Li YH; Li G; Zhao H; Li YP; Xu YY; Zhou HT; Wu Y; Jin MF; Liu L; Zhu XM; Ni J; Wang J; Xing F; Zhao WL; Pan J
J Exp Clin Cancer Res; 2015 Jan; 34(1):4. PubMed ID: 25609158
[TBL] [Abstract][Full Text] [Related]
26. Application of High Throughput Technologies in the Development of Acute Myeloid Leukemia Therapy: Challenges and Progress.
Xiang W; Lam YH; Periyasamy G; Chuah C
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35270002
[TBL] [Abstract][Full Text] [Related]
27. Survival of the Fittest: Darwinian Selection Underpins Chemotherapy Resistance in AML.
MacPherson L; Dawson MA
Cell Stem Cell; 2017 Sep; 21(3):291-292. PubMed ID: 28886361
[TBL] [Abstract][Full Text] [Related]
28. Acute leukemia in adults.
Minden M; Imrie K; Keating A
Curr Opin Hematol; 1996 Jul; 3(4):259-65. PubMed ID: 9372086
[TBL] [Abstract][Full Text] [Related]
29. Emerging epigenetic therapeutics for myeloid leukemia: modulating demethylase activity with ascorbate.
Das AB; Smith-Díaz CC; Vissers MCM
Haematologica; 2021 Jan; 106(1):14-25. PubMed ID: 33099992
[TBL] [Abstract][Full Text] [Related]
30. Recent advance of clinically approved small-molecule drugs for the treatment of myeloid leukemia.
Niu ZX; Wang YT; Sun JF; Nie P; Herdewijn P
Eur J Med Chem; 2023 Dec; 261():115827. PubMed ID: 37757658
[TBL] [Abstract][Full Text] [Related]
31. Insights into the New Molecular Updates in Acute Myeloid Leukemia Pathogenesis.
Demir D
Genes (Basel); 2023 Jul; 14(7):. PubMed ID: 37510328
[TBL] [Abstract][Full Text] [Related]
32. [Advances in the mouse models of myeloid leukemia].
Ge C; Fu C
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2019 Oct; 36(5):885-892. PubMed ID: 31631640
[TBL] [Abstract][Full Text] [Related]
33. Systematic review of epigenetic targets in acute myeloid leukemia.
Verma S; Dhanda H; Singh A; Rishi B; Tanwar P; Chaudhry S; Siraj F; Misra A
Am J Blood Res; 2021; 11(5):458-471. PubMed ID: 34824880
[TBL] [Abstract][Full Text] [Related]
34. Discovery of druggable cancer-specific pathways with application in acute myeloid leukemia.
Trac QT; Zhou T; Pawitan Y; Vu TN
Gigascience; 2022 Sep; 11():. PubMed ID: 36173247
[TBL] [Abstract][Full Text] [Related]
35. New genomic classification of pediatric acute myeloid leukemia.
Nat Genet; 2024 Feb; 56(2):202-203. PubMed ID: 38238630
[No Abstract] [Full Text] [Related]
36. Genomic landscape of hyperleukocytic acute myeloid leukemia.
Largeaud L; Bertoli S; Bérard E; Tavitian S; Picard M; Dufrechou S; Prade N; Vergez F; Rieu JB; Luquet I; Sarry A; Huguet F; Ruiz J; De Mas V; Delabesse E; Récher C
Blood Cancer J; 2022 Jan; 12(1):4. PubMed ID: 34987148
[No Abstract] [Full Text] [Related]
37. Acute Myeloid Leukemia Evolving from Myeloproliferative Neoplasms: Many Sides of a Challenging Disease.
Mannelli F
J Clin Med; 2021 Jan; 10(3):. PubMed ID: 33498691
[TBL] [Abstract][Full Text] [Related]
38. Single-cell genomic profiling of acute myeloid leukemia for clinical use: A pilot study.
Yan B; Hu Y; Ban KHK; Tiang Z; Ng C; Lee J; Tan W; Chiu L; Tan TW; Seah E; Ng CH; Chng WJ; Foo R
Oncol Lett; 2017 Mar; 13(3):1625-1630. PubMed ID: 28454300
[TBL] [Abstract][Full Text] [Related]
39. Genomics of therapy-related myeloid neoplasms.
Kuzmanovic T; Patel BJ; Sanikommu SR; Nagata Y; Awada H; Kerr CM; Przychodzen BP; Jha BK; Hiwase D; Singhal D; Advani AS; Nazha A; Gerds AT; Carraway HE; Sekeres MA; Mukherjee S; Maciejewski JP; Radivoyevitch T
Haematologica; 2020 Mar; 105(3):e98-e101. PubMed ID: 31413096
[No Abstract] [Full Text] [Related]
40. Targeted drug discovery for pediatric leukemia.
Napper AD; Watson VG
Front Oncol; 2013; 3():170. PubMed ID: 23847761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
